In the framework of collaboration with WHO, AVA Pharmaceuticals (Pvt) Ltd company began supplying generic drugs for HIV, hepatitis B and C treatment to different countries of South America
Under the patronage of the World Health Organization, AVA Pharmaceuticals (Pvt) Ltd company began supplying generic drugs to different parts of South America as a part of the humanitarian mission. These generic drugs include some medications that are used for antiretroviral therapy to treat HIV, hepatitis B virus and hepatitis C virus infections.
Nowadays, the company supplies such medicines as:
- Encor (principal active substance – entecavir). This medication is used to treat chronic hepatitis B disease.
- Tafaday (active ingredient – tenofovir alafenamide). This medication has the antiviral activity against hepatitis B virus and HIV.
- Zeprid (each tablet of this preparation contains 300 mg of tenofovir disoproxil fumarate). This medication is active against HIV and hepatitis B virus.
- Sofovel (active ingredients – sofosbuvir and velpatasvir). This drug is used to treat all genotypes of hepatitis C.
- Sofodac (each tablet of this preparation contains 400 mg of sofosbuvir and 60 mg of daclatasvir). This medication is effective against HCV genotypes 2a, 3a, 4a and 1b.
According to the plan, the monthly deliveries will amount to approximately 10000 courses. All medicines are highly effective and comply with international quality and safety standards. Such supplies will be a really great salvation for millions of patients living in South America.